Tomas J. Svoboda

Tomas J. Svoboda

Director Ejecutivo en Elanix Technologies SA .

Health Technology
Consumer Services
Commercial Services

Perfil

Tomas J.
Svoboda
currently works at Elanix Technologies SA, as Chief Executive Officer and Tagator SA, as Chief Executive Officer & Owner from 2005.
Mr. Svoboda also formerly worked at Elanix Biotechnologies AG, as Chief Executive Officer, PRO-MED Medizinische Produktions & Handels AG, as Chief Executive Officer, Haemonetics Corp., as Principal, West Pharmaceutical Services, Inc., as Vice President from 2014 to 2016, and Ares-Serono Group, as Principal.
Mr. Svoboda received his undergraduate degree from INSEAD and Masters Business Admin degree in 2006 from the University of Santa Monica.

Cargos activos de Tomas J. Svoboda

EmpresasCargoInicio
Director Ejecutivo -
Director Ejecutivo 01/04/2005
Todos los cargos activos de Tomas J. Svoboda

Antiguos cargos conocidos de Tomas J. Svoboda.

EmpresasCargoFin
WEST PHARMACEUTICAL SERVICES, INC. Corporate Officer/Principal 01/03/2016
Director Ejecutivo 27/12/2013
ELANIX BIOTECHNOLOGIES AG Director Ejecutivo -
HAEMONETICS CORPORATION Corporate Officer/Principal -
Corporate Officer/Principal -
Ver el detalle de la experiencia de Tomas J. Svoboda.

Formación de Tomas J. Svoboda.

INSEAD Undergraduate Degree
University of Santa Monica Masters Business Admin

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Tomas J. Svoboda.

Relaciones

12

Relaciones de 1er grado

9

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas3
HAEMONETICS CORPORATION

Health Technology

ELANIX BIOTECHNOLOGIES AG

Health Technology

WEST PHARMACEUTICAL SERVICES, INC.

Health Technology

Empresas privadas4

Health Technology

Health Technology

Health Technology

Commercial Services

Ver las conexiones de la empresa
  1. Bolsa de valores
  2. Insiders
  3. Tomas J. Svoboda
-40% Oferta por Tiempo Limitado: Nuestras suscripciones le guían hacia las mejores inversiones del mañana.
APROVÉCHELO AHORA